Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 203
APPENDIX A Workshop Agenda IMPROVING THE TRANSLATION OF RESEARCH FINDINGS INTO CLINICAL PRACTICE: WORKSHOP IV Examining Coverage and Adoption Decisions About Medical Technologies Friday, September 18, 1992 8:30 a.m. Registration and Continental Breakfast 9:00 Welcome and Opening Remarks Kenneth Shine, President, Institute of Medicine SESSION I. SETTING THE STAGE Moderator: Gerald Laubach, Chair, Committee on Technological Innovation in Medicine 9:15 9:45 Discussion The Nature of Technological Change: Incentives Matter! Burton Weisbrod, Northwestern University SESSION II. PROVIDER DECISIONMAKING Moderator: Richard Nesson, Brigham and Women's Hospital 10:00 An Overview of Coverage and Adoption Decisionmaking by Payers and Providers Bryan Luce and Ruth Brown, Battelle 203
OCR for page 203
204 10:30 11:00 1 1:15 1 1:45 Discussion 12:30 Lunch WORKSHOP AGENDA Role of the Hospital in the Acquisition of Technology Gerard Anderson and Earl Steinberg, Johns Hopkins University Break Physicians' Decisions Regarding the Acquisition of Technology Mark Fendrick and Sanford Schwartz, University of Pennsylvania SESSION III. THIRD PARTY PAYER COVERAGE DECISIONS Moderator: Michael Soper, CIGNA The Experience of Blue Cross and Blue Shield Association Susan Gleeson, Blue Cross and Blue Shield Association Decisionmaking at the Health Care Financing Administration Kathleen Buto, Health Care Financing Administration 2:45 3:15 Current and Future Approaches to Coverage in a Group- Model Health Maintenance Organization Paul Lairson, Kaiser Permanente Break High Dose Chemotherapy-Autologous Bone Marrow Trans- plantation: A Model for Health Care Decisionmaking? William McGivney, Aetna Health Plans 4:00 Legal Implications of Experimental Exclusions Lee Newcomer, United HealthCare 4:30 6:00 Discussion Adjournment and Reception Reception Speech: Fishbowl Medicine Versus Muddling Through Uwe Reinhardt, Princeton University
OCR for page 203
WORKSHOP AGENDA Saturday, September 19, 1992 8:00 a.m. Continental Breakfast SESSION IV. INCREASING THE RATIONALITY OF COVERAGE DECISIONMAKING Moderator: Uwe Reinhardt, Princeton University 9:15 9:45 10:15 10:30 11:00 11:30 12:00 12:30 205 Strengthening the Connection Between Evaluative Research and Coverage Decisionmaking Lucian Leape, Harvard School of Public Health Manufacturers' Responses to the Increased Demand for Outcomes Research Ann Marshall, Abbott Laboratories Discussion Break Paying for Evaluative Research Alan Garber, Palo Alto Veterans Administration Medical Center and Stanford University Health Care Reform: Implications for Decisionmaking Susan Bartlett Foote, Staff, U.S. Senate Panel Discussion: Lucian Leape, Harvard School of Public Health Ann Marshall, Abbott Laboratories Alan Garber, Stanford University Susan Bartlett Foote, Staff, U.S. Senate Discussion Summary of the Conference and Adjournment Uwe Reinhardt, Princeton University